The Gut Microbiome Affects Atherosclerosis by Regulating Reverse Cholesterol Transport
- PMID: 38231373
- DOI: 10.1007/s12265-024-10480-3
The Gut Microbiome Affects Atherosclerosis by Regulating Reverse Cholesterol Transport
Abstract
The human system's secret organ, the gut microbiome, has received considerable attention. Emerging research has yielded substantial scientific evidence indicating that changes in gut microbial composition and microbial metabolites may contribute to the development of atherosclerotic cardiovascular disease. The burden of cardiovascular disease on healthcare systems is exacerbated by atherosclerotic cardiovascular disease, which continues to be the leading cause of mortality globally. Reverse cholesterol transport is a powerful protective mechanism that effectively prevents excessive accumulation of cholesterol for atherosclerotic cardiovascular disease. It has been revealed how the gut microbiota modulates reverse cholesterol transport in patients with atherosclerotic risk. In this review, we highlight the complex interactions between microbes, their metabolites, and their potential impacts in reverse cholesterol transport. We also explore the feasibility of modulating gut microbes and metabolites to facilitate reverse cholesterol transport as a novel therapy for atherosclerosis.
Keywords: Atherosclerosis; Cholesterol; Gut microbiome; Reverse cholesterol transport.
© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
The gut microbiome and cardiovascular disease: current knowledge and clinical potential.Am J Physiol Heart Circ Physiol. 2019 Nov 1;317(5):H923-H938. doi: 10.1152/ajpheart.00376.2019. Epub 2019 Aug 30. Am J Physiol Heart Circ Physiol. 2019. PMID: 31469291 Review.
-
Interplay between diet, the gut microbiome, and atherosclerosis: Role of dysbiosis and microbial metabolites on inflammation and disordered lipid metabolism.J Nutr Biochem. 2022 Jul;105:108991. doi: 10.1016/j.jnutbio.2022.108991. Epub 2022 Mar 21. J Nutr Biochem. 2022. PMID: 35331903 Review.
-
Gut Microbially Produced Indole-3-Propionic Acid Inhibits Atherosclerosis by Promoting Reverse Cholesterol Transport and Its Deficiency Is Causally Related to Atherosclerotic Cardiovascular Disease.Circ Res. 2022 Aug 19;131(5):404-420. doi: 10.1161/CIRCRESAHA.122.321253. Epub 2022 Jul 27. Circ Res. 2022. PMID: 35893593
-
The Role of Gut Microbiota on Cholesterol Metabolism in Atherosclerosis.Int J Mol Sci. 2021 Jul 28;22(15):8074. doi: 10.3390/ijms22158074. Int J Mol Sci. 2021. PMID: 34360839 Free PMC article. Review.
-
Gut microbiome and metabolites, the future direction of diagnosis and treatment of atherosclerosis?Pharmacol Res. 2023 Jan;187:106586. doi: 10.1016/j.phrs.2022.106586. Epub 2022 Nov 30. Pharmacol Res. 2023. PMID: 36460280 Review.
Cited by
-
Vascular medicine in the 21st century: Embracing comprehensive vasculature evaluation and multidisciplinary treatment.World J Clin Cases. 2024 Sep 26;12(27):6032-6044. doi: 10.12998/wjcc.v12.i27.6032. World J Clin Cases. 2024. PMID: 39328850 Free PMC article. Review.
References
-
- Costello EK, Lauber CL, Hamady M, Fierer N, Gordon JI, Knight R. Bacterial community variation in human body habitats across space and time. Science (New York, NY). 2009;326(5960):1694–7. https://doi.org/10.1126/science.1177486 . - DOI
-
- Berg G, Rybakova D, Fischer D, Cernava T, Vergès MC, Charles T, et al. Microbiome definition re-visited: old concepts and new challenges. Microbiome. 2020;8(1):103. https://doi.org/10.1186/s40168-020-00875-0 . - DOI - PubMed - PMC
-
- Mishra AK, Dubey V, Ghosh AR. Obesity: an overview of possible role(s) of gut hormones, lipid sensing and gut microbiota. Metabolism: Clin Exp. 2016;65(1):48–65. https://doi.org/10.1016/j.metabol.2015.10.008 . - DOI
-
- Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent M, et al. Diversity of the human intestinal microbial flora. Science (New York, NY). 2005;308(5728):1635–8. https://doi.org/10.1126/science.1110591 . - DOI
-
- Tang WH, Hazen SL. The gut microbiome and its role in cardiovascular diseases. Circulation. 2017;135(11):1008–10. https://doi.org/10.1161/CIRCULATIONAHA.116.024251 . - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical